Brief: S2medical Starts Commercialisation Of Cosmetic Formulation
Sept 13 (Reuters) - S2Medical AB (publ) S2ME.ST :
* STARTS COMMERCIALISATION OF COSMETIC FORMULATION BASED ON
SKIN
HEALTH RESEARCH
* SIGNS LETTER OF INTENT WITH EYRACURE AB
Source text for Eikon: ID:nWkr7gJZWj
Further company coverage: S2ME.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on S2Medical AB (publ)
See all newsBrief: Eyracure Company Part-owned By S2Medical Files For Bankruptcy
Brief: S2Medical Plans Rights Issue To Raise SEK 2.9 Mln
Brief: S2medical H2 Net Sales At SEK 7.5 Mln
Brief: S2medical Signs Exclusive Distribution Agreement In UAE
Brief: S2Medical Validates European Patent For AMP Technology In 18 Countries